Literature DB >> 11828617

Urinary metabolites of French maritime pine bark extract in humans.

K G Düweler1, P Rohdewald.   

Abstract

After oral administration of 5.28 g and 1.06 g of French maritime pine bark extract to a human volunteer, metabolites of some of the components of the extract could be detected. Ferulic acid and taxifolin, conjugated as glucuronide/sulphate, were excreted within 18 h. The peak urinary excretion was observed approximately 2-3 h after intake. Recovery of ferulic acid in urine was 36-43% and 7-8% for taxifolin. Two further metabolites could be identified as delta-(3,4-dihydroxy-phenyl)-gamma-valerolactone and delta-(3-methoxy-4-hydroxyphenyl)-gamma-valerolactone conjugated with glucuronic acid/sulphate. These metabolites could also be detected after intake of 960 mg of a procyanidin fraction of French maritime pine bark extract. Thus, it was shown that procyanidins are metabolised by humans. Both metabolites show maximal urinary excretion 8-12 h after intake and are excreted within 28-34 h.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11828617

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  10 in total

1.  Coumaroyl iridoids and a depside from cranberry (Vaccinium macrocarpon).

Authors:  Allison Turner; Shao-Nong Chen; Dejan Nikolic; Richard van Breemen; Norman R Farnsworth; Guido F Pauli
Journal:  J Nat Prod       Date:  2007-02-02       Impact factor: 4.050

2.  Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

Authors:  Jana Trebatická; Sona Kopasová; Zuzana Hradecná; Kamil Cinovský; Igor Skodácek; Ján Suba; Jana Muchová; Ingrid Zitnanová; Iweta Waczulíková; Peter Rohdewald; Zdenka Duracková
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-13       Impact factor: 4.785

3.  Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile.

Authors:  Sridevi Devaraj; Sonia Vega-López; Nalini Kaul; Frank Schönlau; Peter Rohdewald; Ishwarlal Jialal
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

4.  Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity.

Authors:  Mubeen A Ansari; Jeffrey N Keller; Stephen W Scheff
Journal:  Free Radic Biol Med       Date:  2008-09-09       Impact factor: 7.376

5.  Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol).

Authors:  Tanja Grimm; Zuzana Chovanová; Jana Muchová; Katarína Sumegová; Anna Liptáková; Zdenka Duracková; Petra Högger
Journal:  J Inflamm (Lond)       Date:  2006-01-27       Impact factor: 4.981

6.  Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers.

Authors:  Tanja Grimm; Roswitha Skrabala; Zuzana Chovanová; Jana Muchová; Katarína Sumegová; Anna Liptáková; Zdenka Duracková; Petra Högger
Journal:  BMC Clin Pharmacol       Date:  2006-08-03

Review 7.  Review on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, Pycnogenol.

Authors:  Peter Jörg Rohdewald
Journal:  J Med Food       Date:  2017-08-24       Impact factor: 2.786

8.  Distribution of Constituents and Metabolites of Maritime Pine Bark Extract (Pycnogenol®) into Serum, Blood Cells, and Synovial Fluid of Patients with Severe Osteoarthritis: A Randomized Controlled Trial.

Authors:  Melanie Mülek; Lothar Seefried; Franca Genest; Petra Högger
Journal:  Nutrients       Date:  2017-04-28       Impact factor: 5.717

9.  Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MS(n).

Authors:  Ping Yang; Feng Xu; Hong-Fu Li; Yi Wang; Feng-Chun Li; Ming-Ying Shang; Guang-Xue Liu; Xuan Wang; Shao-Qing Cai
Journal:  Molecules       Date:  2016-09-13       Impact factor: 4.411

10.  Facilitated uptake of a bioactive metabolite of maritime pine bark extract (pycnogenol) into human erythrocytes.

Authors:  Max Kurlbaum; Melanie Mülek; Petra Högger
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.